pH‐sensitive carbon quantum dots−doxorubicin nanoparticles for tumor cellular targeted drug delivery

2019 ◽  
Vol 30 (11) ◽  
pp. 2664-2673 ◽  
Author(s):  
Wen Bao ◽  
Haibo Ma ◽  
Nan Wang ◽  
Zhanhang He
2016 ◽  
Vol 8 (34) ◽  
pp. 22442-22450 ◽  
Author(s):  
Xiaoli Cai ◽  
Yanan Luo ◽  
Weiying Zhang ◽  
Dan Du ◽  
Yuehe Lin

2018 ◽  
Vol 92 ◽  
pp. 892-901 ◽  
Author(s):  
Marziyeh Poshteh Shirani ◽  
Behzad Rezaei ◽  
Taghi Khayamian ◽  
Mohammad Dinari ◽  
Fazileh Hosseini Shamili ◽  
...  

2013 ◽  
Vol 5 (18) ◽  
pp. 8939-8947 ◽  
Author(s):  
Abdallah Laouini ◽  
Konstantinos P. Koutroumanis ◽  
Catherine Charcosset ◽  
Stella Georgiadou ◽  
Hatem Fessi ◽  
...  

2017 ◽  
Vol 19 (3) ◽  
pp. 991-1000 ◽  
Author(s):  
Thisirak Woraphatphadung ◽  
Warayuth Sajomsang ◽  
Theerasak Rojanarata ◽  
Tanasait Ngawhirunpat ◽  
Prasopchai Tonglairoum ◽  
...  

2020 ◽  
Vol 2 (2) ◽  
pp. 35-50
Author(s):  
Pramod Vishwanath Prasad ◽  
Kakali Purkayastha ◽  
Utkarsh Sharma ◽  
Mayadhar Barik

Emergence of various nanoscale drug carrier platforms as Drug Delivery Systems (DDS) has revolutionized the field of medicine.Nonetheless, theside-effects due to non-specific distribution of anticancer therapeutics in normal, healthy tissues remain to be a prime pitfall in curing cancers. Therefore, to achieve a better therapeutic efficacy, the use of a target-specific delivery, combined with a stimuli-responsive nanocarrier system, particularly pH-sensitive nanosystems offer an attractive strategy. Targeted drug delivery through pH-sensitive nanosystems offer the potential to enhance the therapeutic index of anticancer agents, either by increasing the drug concentration in tumor cells and/or by decreasing the exposure in normal host tissues. Therefore, nanoscale-based drug delivery through pH-sensitive nanosystems seem to be a boon for treating gynaecological cancers (as well as other cancers) without side-effects or with least harm to normal healthy tissues.


Sign in / Sign up

Export Citation Format

Share Document